To study the safety and efficacy of Vitamin D3, Vitamin K2-7 & magnesium , in prevention of COVID 19 infection in health care professional (HCP)
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/06/026191
- Lead Sponsor
- Suraksha Pharma Private Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Participants of either sex, 20 to 60 years of age who are at high risk. High-risk individuals are defined as all health care professionals in hospitals, clinics, and emergency rooms, and medical facilities involved in management of COVID -19 patients.
(Doctors, nursing staff, paramedical staff, ambulance staff, other hospital staff, ward attendees coming in contact with COVID -19 patients).
2.Participants who are negative for RT-PCR test for COVID-19 infection
3.Participants who are willing to provide inform consent and willing to come for schedule follow up visit.
4.Participant not having contra indication to take Vitamin D,
5.Participants having no COVID- 19 infection clinically.
6.Signed informed consent, demonstrating that the subject understands the procedures required for the study and the purpose of the study.
1Participants with known allergy or contraindication to Vitamin D ,Vitamin K2-7 & Magnesium .
2History of having received any investigational drug in the preceding one month.
3History of taking any kind of formulation or any other form of therapy for COVID- 19 prophylaxis.
4Unwilling to come for regular follow-up for the entire duration of the study.
5Any condition that, in the opinion of the investigator, does not justify the subjectâ??s inclusion in the study.
6Participants participating in other clinical study.
7Participant receiving other immune enhancers.
8Refusal to sign informed consent form
9Any previous positive test for COVID-19 by RT- PCR
10Symptomatic for COVID-19
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method